Study Objectives: Recent medical evidence and national recommendations suggest that risk stratification tools in the emergency department (ED) can identify patients with possible acute coronary syndrome who are at low risk and do not benefit from further hospital observation or non-invasive cardiac testing. We studied the effect of ED implementation of a care pathway using HEART, a recommended risk stratification tool, on hospital use and non-invasive cardiac testing for chest pain. We hypothesized that hospitalizations and non-invasive cardiac testing would decrease as a result.
Methods: We performed an interrupted time series study of ED encounters from May 2015 to June 2017. The patient population included adults with an ED chest pain diagnosis and troponin lab test completed at 13 Kaiser Permanente Southern California EDs. The primary outcome was hospitalization/observation and/or non-invasive stress testing within 30 days, and the secondary outcome was 30-day all-cause mortality or acute myocardial infarction. A generalized estimating equation segmented logistic regression model was used to compare the odds of the primary outcome pre-and post-HEART implementation. All models were adjusted for patient and facility characteristics and fit using physicians as a clustering variable. Differences in mean rates of the primary outcome pre-and post-were also assessed at each of the study EDs. Results: 65, 871) were included in the study sample. Overall 33.5% (Pre-35.5% and Post-31.8%) ED chest pain encounters resulted in hospitalization/observation, non-invasive stress testing or both. Primary adjusted results found a significant decrease in the primary outcome post implementation (OR 0.984, (Figure 1 ). This change was primarily due to decreases in non-invasive cardiac testing (OR 0.984, . No difference in adverse outcomes were noted (Pre-0.6% and Post-0.6%, OR 1.02, 95% CI 0.97-1.08). Differences in impact of the HEART pathway varied by medical center (Figure 2) .
Conclusions: Implementation of a HEART pathway used in the ED evaluation of patients with chest pain resulted in less inpatient care and non-invasive cardiac testing. Standardizing acute chest pain management can improve the efficiency and quality of care.
history and laboratory values were imported directly from the EHR. Prior to receiving risk stratification estimates, physicians entered their gestalt using a sliding scale (0-100). Mixed effects linear regression was used to explore associations between clinical variables, including interaction terms, and physician gestalt. Model variables with p-values <0.01 were considered statistically significant.
Results: From 1/1/2018 to 4/30/2018, there were 2,803 completed enrollments by 372 unique emergency physicians. The median patient age was 57 and 47.5% were male. The median physician gestalt was 10 (IQR 5-21). Variables positively associated with increased physician gestalt, in descending order of strength, included the presence of an elevated troponin, ischemic ECG, crescendo angina, exertional symptoms, diaphoresis, radiation of pain, abnormal nonischemic ECG, family history of premature ACS, and increasing age (Table 1) . Female sex, sharp/stabbing pain, and pain that was worse with palpation had significant negative associations with gestalt (Table 1) . History of smoking, coronary artery disease, coronary revascularization, diabetes, stroke, obesity, hyperlipidemia, peripheral vascular disease, aortic atherosclerosis, myocardial infarction, or hypertension and symptoms of dyspnea at rest, nausea/vomiting, anxiety, or pain worse with inspiration were not independently associated with gestalt (p>0.01 for all). Interaction term testing found strong negative interactions between exertional symptoms and pain with inspiration (p¼0.015) and significant positive interactions between crescendo angina and a history of coronary revascularization (p<0.001).
Conclusions: The variables most strongly associated with gestalt were troponin maximum, ischemic ECG, crescendo angina, and exertional symptoms. The concomitant presence of atypical symptoms strongly dampened the association between gestalt and exertional symptoms, while the presence of both crescendo angina and prior coronary revascularization synergistically amplified gestalt. This is notable in that neither crescendo angina nor exertional symptoms are explicit components of currently validated ED chest pain risk scores. Provider acceptance of risk scores might be improved by incorporation of these 2 variables. Study Objectives: Anxiety is thought to be a significant contributor to chest pain symptoms in approximately 40% of patients with low risk chest pain seen in the emergency department (ED). The validated Hospital Anxiety Depression Scale -Anxiety subscale (HADS-A) has been used as an anxiety screening tool in this population. These patients have been shown to have persistent anxiety symptoms at follow-up and significantly higher ED utilization. The objective of this study was to determine the prevalence of abnormal anxiety levels in a cohort of low-risk chest pain patients and characterize their comorbid psychological contributors. We hypothesized that those with abnormal anxiety scores would have worse concomitant depression, optimism and pain catastrophizing scores in addition to experiencing more life trauma.
Methods: This was a pre-planned secondary analysis of a single-center, prospective observational cohort study of ED subjects with low risk chest pain. Eligible subjects between 18 and 70 years old with no history of acute coronary syndrome (ACS) and a physician-reported HEART score < 4, were enrolled. The HADS-A was used to stratify participants into 2 groups: Low Anxiety (score<8) and High Anxiety (score8). Outcomes assessed included concomitant depression via the Hospital Anxiety Depression ScaleDepression subscale (HADS-D), previous trauma (Traumatic Life Events Questionnaire), optimism (Life Optimism Test-Revised), and pain catastrophizing (Pain Catastrophizing Scale). These groups were analyzed and compared using t-tests for continuous data and chi-square for proportional/ categorical data.
Results: Of 442 screened subjects, 304 met enrollment criteria and 163 (36.8%) gave informed consent. Seventy-six (47%) were stratified into the High Anxiety group with a score8. There were no differences in baseline demographics between groups. Overall, there was a moderate positive correlation between HADS-A and HADS-D scores with a Pearson's R of 0.519. Thirty percent of all subjects had abnormal depression scores 8 on the HADS-D and 35 subjects (45%) had both abnormal anxiety as well as depression. Mean depression scores were significantly different between the low anxiety and high anxiety groups (3.64, 95% CI 2.17 to 5.10). Traumatic experiences of assault with a weapon (p¼0.000), physical assault (p¼0.012), sexual assault (p¼0.046), witnessing fire (p¼0.034), natural disaster (p¼0.035) were all associated with abnormal levels of anxiety. However, only sexual assault (p¼0.030) and other unwanted sexual encounters (p¼0.040) were associated with abnormal levels of depression. Optimism was negatively correlated with both anxiety (R¼-0.489) and depression (R¼-0.504). Additionally, optimism was significantly lower for subjects with either abnormal anxiety (mean difference of 3.86, 95% CI 2.46 to 5.26) or abnormal depression (mean difference 4.32, 95% CI 2.80 to 5.83). Pain catastrophizing was also significantly higher in subjects with either abnormal anxiety or depression (p¼0.000).
Conclusions: The prevalence of abnormal levels of anxiety in our low risk chest pain cohort was 47%. These patients were more likely to have concurrent symptoms of depression, multiple traumatic exposures, a less optimistic outlook, and a pain catastrophizing phenotype. These data indicate there may be an opportunity to address these problems in many low risk chest pain patients as a best practice.
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A Data-Driven Approach to Identifying Acute Coronary Syndrome in the Emergency Department Sutton N, Smith S, Plumley J, Tamayo-Sarver J, Butler I/Vituity, Emeryville, CA Study Objectives: Develop a data-driven cardiac risk stratification tool using advanced analytics and machine learning.
Methods: Using historical patient data from 2 large community health centers, we created a gradient boosted algorithm using a dataset of 677,577 patient encounters. We then applied this algorithm to a smaller dataset of 3,375 patients who were treated through a chest pain model centered on the HEART score. We
